Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Head & Face Medicine
Published in: Head & Face Medicine 1/2015

Open Access 01-12-2015 | Review

Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma - a systematic review

Author: Esam Omar

Published in: Head & Face Medicine | Issue 1/2015

Login to get access

Abstract

Background

Oral squamous cell carcinoma (OSCC) has a remarkably high incidence worldwide, and a fairly serious prognosis, encouraging further research into advanced technologies for noninvasive methods of making early diagnoses, ideally in primary care settings.

Objectives

Our purpose was to examine the validity of using advanced noninvasive technologies in diagnosis of OSCC by identifying and evaluating relevant published reports.

Data source

MEDLINE, EMBASE, and CINAHL were searched to identify clinical trials and other information published between 1990 and 10 June 2014; the searches of MEDLINE and EMBASE were updated to November 2014. Study selection: Studies of noninvasive methods of diagnosing OSCC, including oral brush biopsy, optical biopsy, saliva-based oral cancer diagnosis, and others were included.

Data extraction

Data were abstracted and evaluated in duplicate for possible relevance on two occasions at an interval of 2 months before being included or excluded.

Data synthesis

This study identified 163 studies of noninvasive methods for diagnosing OSCC that met the inclusion criteria. These included six studies of oral brush biopsy, 42 of saliva-based oral diagnosis, and 115 of optical biopsy. Sixty nine of these studies were assessed by the modified version of the QUADAS instrument. Saliva-based oral cancer diagnosis and optical biopsy were found to be promising noninvasive methods for diagnosing OSCC.

Limitation

The strength of evidence was rated low for accuracy outcomes because the studies did not report important details required to assess the risk for bias.

Conclusions

It is clear that screening for and early detection of cancer and pre-cancerous lesions have the potential to reduce the morbidity and mortality of this disease. Advances in technologies for saliva-based oral diagnosis and optical biopsy are promising pathways for the future development of more effective noninvasive methods for diagnosing OSCC that are easy to perform clinically in primary care settings.
Literature
1.
Dolan RW, Vaughan CW, Fuleihan N. Symptoms in early head and neck cancer: an inadequate indicator. Otolaryngol Head Neck Surg. 1998;119(5):463–7.PubMed
2.
Vernham GA, Crowther JA. Head and neck carcinoma – stage at presentation. Clin Otolaryngol Allied Sci. 1994;19(2):120–4.PubMed
3.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:10.1016/j.cell.2011.02.013. Review.PubMed
4.
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. Review.PubMed
5.
Lazebnik Y. What are the hallmarks of cancer? Nat Rev Cancer. 2010;10(4):232–3.PubMed
6.
Regezi JA, Sciubba JJ, Jordan RCK. Oral pathology: clinical pathologic correlations. 5th ed. St. Louis: Saunders; 2007.
7.
Acha A, Ruesga MT, Rodriguez MJ, Pancorbo MA, Aguirre JM. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal. 2005;2:95–102.
8.
NIMIT. Novel instruments for minimally invasive techniques, Plan for a Centre of Research Excellence. Zeist: A-D Druk B.V; 2010.
9.
Bouquot JE. Common oral lesions found during a mass screening examination. J Am Dent Assoc. 1986;112(1):50–7.PubMed
10.
Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:537–47.PubMed
11.
Culling CF, Allison TR. ellular Pathology Technique. 4th ed. London: Butterworths; 1985.
12.
Mandel ID. Salivary diagnosis: more than a lick and a promise. J Am Dent Assoc. 1993;124:85–7.PubMed
13.
Lee JM, Garon E, Wong DT. Salivary diagnostics. Orthod Craniofac Res. 2009;12(3):206–11. doi:10.1111/j.1601-6343.2009.01454.x. Review.PubMedPubMedCentral
14.
Crouch S, Skoog DA. Principles of instrumental analysis. Australia: Thomson Brooks/Cole; 2007. ISBN 0-495-01201-7.
15.
Peacock ZS, Pogrel MA, Schmidt BL. Exploring the reasons for delay in treatment of oral cancer. J Am Dent Assoc. 2008;139(10):1346–52.PubMed
16.
Yu T, Wood RE, Tenenbaum HC. Delays in diagnosis of head and neck cancers. J Can Dent Assoc. 2008;74(1):61.PubMed
17.
Allison P, Locker D, Feine JS. The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. Oral Oncol. 1998;34(3):161–70.PubMed
18.
Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(4):929–36.PubMed
19.
Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.PubMedPubMedCentral
20.
Cook DJ. Cellular Pathology, second edition. Scion Publishing Ltd; 2Rev Ed edition (3 July 2006). ISBN-13: 978–1904842309.
21.
Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol. 1989;67:621–7.PubMed
22.
Mashberg A. Toluidine blue. J Can Dent Assoc. 1995;61(11):922–44.PubMed
23.
Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(4):444–6.PubMed
24.
Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol. 2004;40(8):824–8.PubMed
25.
Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. J Am Dent Assoc. 1999;130:1445–57.PubMed
26.
Gupta A, Singh M, Ibrahim R, Mehrotra R. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions. Acta Cytol. 2007;51(5):788–94.PubMed
27.
Scully C, Bagan JV, Hopper C, Epstein JB. Oral cancer: current and future diagnostic techniques. Am J Dent. 2008;21(4):199–209.PubMed
28.
Poate TW, Buchanan JA, Hodgson TA, Speight PM, Barrett AW, Moles DR, et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol. 2004;40(8):829–34.PubMed
29.
Weigum SE, Floriano PN, Redding SW, Yeh CK, Westbrook SD, McGuff HS, et al. Nano-bio-chip sensor platform for examination of oral exfoliative cytology. Cancer Prev Res (Phila). 2010;3(4):518–28.
30.
Mandel ID. The diagnostic uses of saliva. J Oral Pathol Med. 1990;19(3):119–25.PubMed
31.
Jokerst JV, McDevitt JT. Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care. Nanomed. 2010;5(1):143–55.
32.
Wei F, Patel P, Liao W, Chaudhry K, Zhang L, Arellano-Garcia M, et al. Electrochemical sensor for multiplex biomarkers detection. Clin Cancer Res. 2009;15(13):4446–52.PubMedPubMedCentral
33.
Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem. 2009;55(8):1530–8.PubMed
34.
Liu C, Qiu X, Ongagna S, Chen D, Chen Z, Abrams WR, et al. A timer-actuated immunoassay cassette for detecting molecular markers in oral fluids. Lab Chip. 2009;9(6):768–76.PubMed
35.
36.
37.
Xie H, Onsongo G, Popko J, de Jong EP, Cao J, Carlis JV, et al. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics. 2008;7(3):486–98.PubMed
38.
Williams MD. Integration of biomarkers including molecular targeted therapies in head and neck cancer. Head Neck Pathol. 2010;4(1):62–9.PubMedPubMedCentral
39.
Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M, et al. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6(1):78–95.PubMed
40.
41.
Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14(19):6246–52. doi:10.1158/1078-0432.CCR-07-5037.PubMedPubMedCentral
42.
Bigler LR, Streckfus CF, Dubinsky WP. Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity. Clin Lab Med. 2009;29(1):71–85.PubMed
43.
Bilodeau E, Alawi F, Costello BJ, Prasad JL. Molecular diagnostics for head and neck pathology. Oral Maxillofac Surg Clin North Am. 2010;22(1):183–94.PubMed
44.
Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000;6(2):357–62.PubMed
45.
Markopoulos AK, Michailidou EZ, Tzimagiorgis G. Salivary markers for oral cancer detection. The Open Dent J. 2010;4:171–8.
46.
Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287:2017–9.PubMed
47.
Tilakaratne WM. Oral cavity and major and minor salivary glands. In: The Cancer Handbook. 2nd ed. United States: John Wiley and Sons Ltd; 2007. p. 1–15.
48.
Boyle JO, Hakim J, Koch W, Van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993;53:4477–80.PubMed
49.
Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol. 2006;7:77–82.PubMed
50.
Rosas SL, Koch W, Da Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001;61:939–42.PubMed
51.
Das BR, Nagpal JK. Understanding the biology of oral cancer. Med Sci Monit. 2002;8:RA258–67.PubMed
52.
Chien DX, Schwartz PE. Saliva and serum CA 125 assays for detecting malignant ovarian tumors. Obstet Gynecol. 1990;75:701–4.
53.
Zimmermann BG, Wong DT. Salivary mRNA targets for cancer diagnostics. Oral Oncol. 2008;44:425–9.PubMed
54.
Handschel J, Oz D, Pomjanski N, Depprich R, Ommerborn MA, Braunstein S, et al. Additional use of DNA-image cytometry improves the assessment of resection margins. J Oral Pathol Med. 2007;36(8):472–5.PubMed
55.
Hasselmann D, Rappl G, Tilgen W, Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem. 2001;47:1488–9.PubMed
56.
Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006;20:1487–95.PubMed
57.
García JM, García V, Peña C, Domínguez G, Silva J, Diaz R, et al. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. RNA. 2008;14:1424–32.PubMedPubMedCentral
58.
Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: Current perspectives. Proteomics. 2008;8:4083–99.PubMed
59.
Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–6.PubMedPubMedCentral
60.
Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and Genomics. JADA. 2006;137:313–21.PubMed
61.
Speight PM, Morgan PR. The natural history and pathology of oral cancer and precancer. Comm Dent Health. 1993;10 Suppl 1:31–41.
62.
Shankar AA, Alex S, Routray S. Incorporation of salivary metabolomics in oral cancer diagnostics. Oral Oncol. 2014;50(10):e53–4.PubMed
63.
Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I, et al. Salivary analysis of oral cancer biomarkers. Br J Cancer. 2009;101:1194–8.PubMedPubMedCentral
64.
Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, et al. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol. 2008;34(4):450–5.PubMed
65.
St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929–35.PubMed
66.
Rajkumar K, Kumar AR, Ramyamalini V, Nandhini G, Kumar TD, Ashwini BK, et al. Estimation of serological and salivary biomarkers in patients with Oral Squamous cell carcinoma, premalignant lesions and conditions. SRM Univ J Dent Sci. 2010;1:14–9.
67.
Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. NF-kappa B dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005;29:42–5.PubMed
68.
Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, Chia D, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008;14:705–12.PubMedPubMedCentral
69.
Epstein JB, Gorsky M, Lonky S, Silverman Jr S, Epstein JD, Bride M. The efficacy of oral lumenoscopy™ (ViziLite®) in visualizing oral mucosal lesions. Spec Care Dentist. 2006;26(4):171–4.PubMed
70.
Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent. 2006;17(3):59–63.PubMed
71.
Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg. 2005;34(5):521–7.PubMed
72.
Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite™) in the visualisation of oral mucosal white lesions. Oral Oncol. 2007;43:820–4.PubMed
73.
Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg. 2007;65(3):424–6.PubMed
74.
Gillenwater A. Optical technologies for detection and diagnosis of oral neoplasia. Head & Neck Oncology. 2009;1 Suppl 1:011.
75.
Ramanujam N. Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia. 2000;2:1–29.
76.
De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol. 2005;41:356–64.
77.
Lakowicz JR. Principles of fluorescence spectroscopy. 3. New York: Kluwer Academic/Plenum; 2006.
78.
Mycek M-A, Pogue BW. Handbook of Biomedical Fluorescence. New York: Marcel Dekker, Inc; 2003.
79.
Richards-Kortum R, Sevick-Muraca E. Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem. 1996;47:555–606 [PubMed].PubMed
80.
Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol. 1998;68:603–32.PubMed
81.
Elson D, Galletly N, Talbot C. Multidimensional Fluorescence Imaging applied to biological tissues. In: Geddes C, Lakowicz JR, editors. Reviews in Fluorescence 2006. 2006. p. 524–77.
82.
Chorvat D, Chorvatova A. Multi-wavelength fluorescence lifetime spectroscopy: a new approach to the study of endogenous fluorescence in living cells and tissues. Lasers Phys Lett. 2009;6:175–93.
83.
Haj-Hosseini N, Richter J, Andersson-Engels S, Wardell K. Optical touch pointer for fluorescence guided glioblastoma resection using. 5-aminolevulinic acid. Lasers Surg Med. 2010;42:9–14.PubMed
84.
Andersson-Engels S, Klinteberg C, Svanberg K, Svanberg S. In vivo fluorescence imaging for tissue diagnostics. Phys Med Biol. 1997;42:815–24.PubMed
85.
Bigio IJ, Mourant JR. Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy. Phys Med Biol. 1997;42:803–14.PubMed
86.
Cubeddu R, Comelli D, D’Andrea C, Taroni P, Valentini G. Time-resolved fluorescence imaging in biology and medicine. J Phys D Appl Phys. 2002;35:R61–76.
87.
Das BB, Liu F, Alfano RR. Time-resolved fluorescence and photon migration studies in biomedical and model random media. Rep Prog Phys. 1997;60:227–92.
88.
Coghlan L, Utzinger U, Richards-Kortum R, Brookner C, Zuluaga A, Gimenez-Conti I, et al. Fluorescence spectroscopy of epithelial tissue throughout the dysplasia-carcinoma sequence in an animal model: spectroscopic changes precede morphologic changes. Lasers Surg Med. 2001;29(1):1–10.PubMed
89.
Georgakoudi I, Rice WL, Hronik-Tupaj M, Kaplan DL. Optical spectroscopy and imaging for the noninvasive evaluation of engineered tissues. Tissue Eng Part B Rev. 2008;14:321–40.PubMedPubMedCentral
90.
Ashjian P, Elbarbary A, Zuk P, DeUgarte DA, Benhaim P, Marcu L, et al. Noninvasive in situ evaluation of osteogenic differentiation by time-resolved laser-induced fluorescence spectroscopy. Tissue Eng. 2004;10:411–20 [PubMed].PubMed
91.
Fite BZ, Decaris M, Sun Y, Sun Y, Lam A, Ho CK, et al. Noninvasive multimodal evaluation of bioengineered cartilage constructs combining time-resolved fluorescence and ultrasound imaging. Tissue Eng Part C Methods. 2011;17:495–504.PubMedPubMedCentral
92.
Utzinger U, Richards-Kortum RR. Fiber optic probes for biomedical optical spectroscopy. J Biomed Opt. 2003;8:121–47.PubMed
93.
94.
95.
96.
97.
98.
99.
Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res. 2006;12(22):6716–22.PubMed
100.
Betz CS, Makriniotis T, Stepp H, Jerjes W, Upile T, Hopper C, et al. Diagnosis of head & neck malignancy using fluorescence spectroscopy and imaging. Head Neck Oncol. 2009;1 Suppl 1:04.
101.
Stepp H, Johansson A, Betz CS, Leunig A. Fluorescence spectroscopy and fluorescence imaging for tissue diagnostics – principles and methods. Head & Neck Oncology. 2009;1 Suppl 1:03.
102.
Betz CS, Mehlmann M, Rick K, Stepp H, Grevers G, Baumgartner R, et al. Autofluorescence imaging and spectroscopy of normal and malignant mucosa in patients with head and neck cancer. Lasers Surg Med. 1999;25(4):323–34.PubMed
103.
Kulbersh BD, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg. 2007;133(5):511–5.PubMed
104.
Mayinger B, Horner P, Jordan M, Gerlach C, Horbach T, Hohenberger W, et al. Light-induced autofluorescence spectroscopy for the endoscopic detection of esophageal cancer. Gastrointest Endosc. 2001;54(2):195–201.PubMed
105.
Suhr MA, Hopper C, Jones L, George JG, Bown SG, MacRobert AJ. Optical biopsy systems for the diagnosis and monitoring of superficial cancer and precancer. Int J Oral Maxillofac Surg. 2000;29(6):453–7.PubMed
106.
Upile T, Jerjes W, Sterenborg HJ, El-Naggar AK, Sandison A, Witjes MJ, et al. Head & neck optical diagnostics: vision of the future of surgery. Head Neck Oncol. 2009;1:25. doi:10.1186/1758-3284-1-25.PubMedPubMedCentral
107.
Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, et al. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol. 2010;2:9.PubMedPubMedCentral
108.
Sharwani A, Jerjes W, Salih V, MacRobert AJ, El-Maaytah M, Khalil HS, et al. Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B. 2006;83(1):27–33.PubMed
109.
Gillenwater A, Jacob R, Ganeshappa R, Kemp B, El-Naggar AK, Palmer JL, et al. Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. Arch Otolaryngol Head Neck Surg. 1998;124(11):1251–8.PubMed
110.
Heintzelman DL, Utzinger U, Fuchs H, Zuluaga A, Gossage K, Gillenwater AM, et al. Optimal excitation wavelengths for in vivo detection of oral neoplasia using fluorescence spectroscopy. Photochem Photobiol. 2000;72(1):103–13.PubMed
111.
de Veld DC, Sterenborg HJ, Roodenburg JL, Witjes MJ. Effects of individual characteristics on healthy oral mucosa autofluorescence spectra. Oral Oncol. 2004;40(8):815–23.PubMed
112.
Betz CS, Stepp H, Janda P, Arbogast S, Grevers G, Baumgartner R, et al. A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer. 2002;97(2):245–52.PubMed
113.
Betz CS, Lai JP, Xiang W, Janda P, Heinrich P, Stepp H, et al. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci. 2002;1(5):315–9.PubMed
114.
Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, et al. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope. 2000;110(1):78–83.PubMed
115.
Ebenezar J, Ganesan S, Aruna P, Muralinaidu R, Renganathan K, Saraswathy TR. Noninvasive fluorescence excitation spectroscopy for the diagnosis of oral neoplasia in vivo. J Biomed Opt. 2012;17(9):97007–11.PubMed
116.
Shin D, Vigneswaran N, Gillenwater A, Kortum RR. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol. 2010;6(7):1143–54.PubMedPubMedCentral
117.
Hanlon EB, Manoharan R, Koo TW, Shafer KE, Motz JT, Fitzmaurice M, et al. Prospects for in vivo Raman spectroscopy. Phys Med Biol. 2000;45(2):R1–59. Review.PubMed
118.
Swain RJ, Stevens MM. Raman microspectroscopy for non-invasive biochemical. analysis of single cells. Biochem Soc Trans. 2007;35(Pt 3):544–9.PubMed
119.
Witjes MJH. Raman spectroscopy in clinical diagnosis of head & neck pathology. Head & Neck Oncology. 2009;1 Suppl 1:08.
120.
Duraipandian S, Sylvest Bergholt M, Zheng W, Yu Ho K, Teh M, Guan Yeoh K, et al. Real-time Raman spectroscopy for in vivo, online gastric cancer diagnosis during clinical endoscopic examination. J Biomed Opt. 2012;17(8):081418.PubMed
121.
Stone N, Stavroulaki P, Kendall C, Birchall M, Barr H. Raman spectroscopy for early detection of laryngeal malignancy: preliminary results. Laryngoscope. 2000;110(10 Pt 1):1756–63.PubMed
122.
Lau DP, Huang Z, Lui H, Anderson DW, Berean K, Morrison MD, et al. Raman spectroscopy for optical diagnosis in the larynx: preliminary findings. Lasers Surg Med. 2005;37(3):192–200.PubMed
123.
Lau DP, Huang Z, Lui H, Man CS, Berean K, Morrison MD, et al. Raman spectroscopy for optical diagnosis in normal and cancerous tissue of the nasopharynx-preliminary findings. Lasers Surg Med. 2003;32(3):210–4.PubMed
124.
Gniadecka M, Philipsen PA, Sigurdsson S, Wessel S, Nielsen OF, Christensen DH, et al. Melanoma diagnosis by Raman spectroscopy and neural networks: structure alterations in proteins and lipids in intact cancer tissue. J Invest Dermatol. 2004;122(2):443–9.PubMed
125.
Harris AT, Rennie A, Waqar-Uddin H, Wheatley SR, Ghosh SK, Martin-Hirsch DP, et al. Raman spectroscopy in head and neck cancer. Head Neck Oncol. 2010;2:26.PubMedPubMedCentral
126.
Harris AT, Garg M, Yang XB, Fisher SE, Kirkham J, Smith DA, et al. Raman spectroscopy and advanced mathematical modelling in the discrimination of human thyroid cell lines. Head Neck Oncol. 2009;1:38.PubMedPubMedCentral
127.
Krishnakumar N, Sulfikkarali NK, Manoharan S, Venkatachalam P. Raman spectroscopic investigation of the chemopreventive response of naringenin and its nanoparticles in DMBA-induced oral carcinogenesis. Spectrochim Acta A Mol Biomol Spectrosc. 2013;115:648–53.PubMed
128.
Sahu A, Sawant S, Mamgain H, Krishna CM. Raman spectroscopy of serum: an exploratory study for detection of oral cancers. Analyst. 2013;138(14):4161–74.PubMed
129.
Singh SP, Deshmukh A, Chaturvedi P, Murali Krishna C. In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa. J Biomed Opt. 2012;10:105002.
130.
Singh SP, Sahu A, Deshmukh A, Chaturvedi P, Krishna CM. In vivo Raman spectroscopy of oral buccal mucosa: a study on malignancy associated changes (MAC)/cancer field effects (CFE). Analyst. 2013;138(14):4175–82.PubMed
131.
Deshmukh A, Singh SP, Chaturvedi P, Krishna CM. Raman spectroscopy of normal oral buccal mucosa tissues: study on intact and incised biopsies. J Biomed Opt. 2011;16(12):127004.PubMed
132.
Oliveira AP, Bitar RA, Silveira L, Zângaro RA, Martin AA. Near-infrared Raman spectroscopy for oral carcinoma diagnosis. Photomed Laser Surg. 2006;24(3):348–53.PubMed
133.
Malini R, Venkatakrishna K, Kurien J, Pai KM, Rao L, Kartha VB, et al. Discrimination of normal, inflammatory, premalignant, and malignant oral tissue: a Raman spectroscopy study. Biopolymers. 2006;81(3):179–93.PubMed
134.
Krishna CM, Sockalingum GD, Kurien J, Rao L, Venteo L, Pluot M, et al. Micro-Raman spectroscopy for optical pathology of oral squamous cell carcinoma. Appl Spectrosc. 2004;58(9):1128–35. PubMed.PubMed
135.
Jerjes W, Swinson B, Pickard D, Thomas GJ, Hopper C. Detection of cervical intranodal metastasis in oral cancer using elastic scattering spectroscopy. Oral Oncol. 2004;40(7):673–8.PubMed
136.
Guze K, Pawluk HC, Short M, Zeng H, Lorch J, Norris C, et al. Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. Head Neck. 2014 Feb 15. doi:10.1002/hed.23629.
137.
Hopper C. The clinical application of elastic scattering spectroscopy in the head and neck. Head & Neck Oncology. 2009;1 Suppl 1:02.
138.
Bigio IJ. Elastic light scattering spectroscopy for the detection of pre-cancer: an overview. Head & Neck Oncology. 2009;1 Suppl 1:01.
139.
Müller MG, Valdez TA, Georgakoudi I, Backman V, Fuentes C, Kabani S, et al. Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer. 2003;97(7):1681–92.PubMed
140.
Mourant JR, Canpolat M, Brocker C, Esponda-Ramos O, Johnson TM, Matanock A, et al. Light scattering from cells: the contribution of the nucleus and the effects of proliferative status. J Biomed Opt. 2000;5(2):131–7.PubMed
141.
Mourant JR, Hielscher AH, Eick AA, Johnson TM, Freyer JP. Evidence of intrinsic differences in the light scattering properties of tumorigenic and nontumorigenic cells. Cancer. 1998;84(6):366–74.PubMed
142.
Lovat LB, Johnson K, Mackenzie GD, Clark BR, Novelli MR, Davies S. Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett’s oesophagus. Gut. 2006;55(8):1078–83.PubMedPubMedCentral
143.
Sharwani A, Jerjes W, Salih V, Swinson B, Bigio IJ, El-Maaytah M, et al. Assessment of oral premalignancy using elastic scattering spectroscopy. Oral Oncol. 2006;42(4):343–9.PubMed
144.
Canpolat M, Akman-Karakaş A, Gökhan-Ocak GA, Başsorgun IC, Akif Çiftçioğlu M, Alpsoy E. Diagnosis and demarcation of skin malignancy using elastic light single-scattering spectroscopy: a pilot study. Dermatol Surg. 2012;38(2):215–23.PubMed
145.
Upile T, Jerjes W, Radhi H, Mahil J, Rao A, Hopper C. Elastic scattering spectroscopy in assessing skin lesions: an “in vivo” study. Photodiagnosis Photodyn Ther. 2012;9(2):132–41.PubMed
146.
Qi J, Barrière C, Wood TC, Elson DS. Polarized multispectral imaging in a rigid endoscope based on elastic light scattering spectroscopy. Biomed Opt Express. 2012;3(9):2087–99.PubMedPubMedCentral
147.
A’Amar OM, Liou L, Rodriguez-Diaz E, De las Morenas A, Bigio IJ. Comparison of elastic scattering spectroscopy with histology in ex vivo prostate glands: potential application for optically guided biopsy and directed treatment. Lasers Med Sci. 2013;28(5):1323–9.PubMed
148.
Denkçeken T, Simşek T, Erdoğan G, Peştereli E, Karaveli S, Özel D, et al. Elastic light single-scattering spectroscopy for the detection of cervical precancerous ex vivo. IEEE Trans Biomed Eng. 2013;60(1):123–7.PubMed
149.
Lau C, Sćepanović O, Mirkovic J, McGee S, Yu CC, Fulghum S, et al. Re-evaluation of model-based light-scattering spectroscopy for tissue spectroscopy. J Biomed Opt. 2009;14(2):024031.PubMedPubMedCentral
150.
Amelink A, Sterenborg HJ, Bard MP, Burgers SA. In vivo measurement of the local optical properties of tissue by use of differential path-length spectroscopy. Opt Lett. 2004;29(10):1087–9.PubMed
151.
Sterenborg HJCM, Witjes MJH, De Visscher S, Amelink A. Differential pathlength spectroscopy for diagnosis of head and neck cancer. Head & Neck Oncology. 2009;1 Suppl 1:07.
152.
Amelink A, Sterenborg HJ, Roodenburg JL, Witjes MJ. Non-invasive measurement of the microvascular properties of non-dysplastic and dysplastic oral leukoplakias by use of optical spectroscopy. Oral Oncol. 2011;47(12):1165–70.PubMed
153.
de Visscher SA, Witjes MJ, Kascáková S, Sterenborg HJ, Robinson DJ, Roodenburg JL, et al. In vivo quantification of photosensitizer concentration using fluorescence differential path-length spectroscopy: influence of photosensitizer formulation and tissue location. J Biomed Opt. 2012;17(6):067001.PubMed
154.
Karakullukcu B, Kanick SC, Aans JB, Sterenborg HJ, Tan IB, Amelink A, et al. Clinical feasibility of monitoring m-THPC mediated photodynamic therapy by means of fluorescence differential path-length spectroscopy. J Biophotonics. 2011;4(10):740–51.PubMed
155.
Kanick SC, Sterenborg HJ, Amelink A. Empirical model description of photon path length for differential path length spectroscopy: combined effect of scattering and absorption. J Biomed Opt. 2008;13(6):064042.PubMed
156.
Tsai MT, Lee HC, Lee CK, Yu CH, Chen HM, Chiang CP, et al. Effective indicators for diagnosis of oral cancer using optical coherence tomography. Opt Express. 2008;16(20):15847–62.PubMed
157.
Tsai MT, Lee CK, Lee HC, Chen HM, Chiang CP, Wang YM, et al. Differentiating oral lesions in different carcinogenesis stages with optical coherence tomography. J Biomed Opt. 2009;14(4):044028.PubMed
158.
Kim CS, Wilder-Smith P, Ahn YC, Liaw LH, Chen Z, Kwon YJ. Enhanced detection of early-stage oral cancer in vivo by optical coherence tomography using multimodal delivery of gold nanoparticles. J Biomed Opt. 2009;14(3):034008.PubMedPubMedCentral
159.
Tsai MT, Lee HC, Lu CW, Wang YM, Lee CK, Yang CC, et al. Delineation of an oral cancer lesion with swept-source optical coherence tomography. J Biomed Opt. 2008;13(4):044012.PubMed
160.
Smith LE, Hearnden V, Lu Z, Smallwood R, Hunter KD, Matcher SJ, et al. Evaluating the use of optical coherence tomography for the detection of epithelial cancers in vitro. J Biomed Opt. 2011;16(11):116015.PubMed
161.
Ahn YC, Chung J, Wilder-Smith P, Chen Z. Multimodality approach to optical early detection and mapping of oral neoplasia. J Biomed Opt. 2011;16(7):076007.PubMedPubMedCentral
162.
Wilder-Smith P, Hammer-Wilson MJ, Zhang J, Wang Q, Osann K, Chen Z, et al. In vivo imaging of oral mucositis in an animal model using optical coherence tomography and optical Doppler tomography. Clin Cancer Res. 2007;13(8):2449–54.PubMed
163.
Wilder-Smith P, Lee K, Guo S, Zhang J, Osann K, Chen Z, et al. In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients. Lasers Surg Med. 2009;41(5):353–7.PubMedPubMedCentral
164.
Jerjes W, Upile T, Conn B, Hamdoon Z, Betz CS, McKenzie G, et al. In vitro examination of suspicious oral lesions using optical coherence tomography. Br J Oral Maxillofac Surg. 2010;48(1):18–25.PubMed
165.
Olivo M, Bhuvaneswari R, Keogh I. Advances in bio-optical imaging for the diagnosis of early oral cancer. Pharmaceutics. 2011;3(3):354–78.PubMedPubMedCentral
166.
Volgger V, Stepp H, Ihrler S, Kraft M, Leunig A, Patel PM, et al. Evaluation of optical coherence tomography to discriminate lesions of the upper aerodigestive tract. Head Neck. 2013;35(11):1558–66.PubMed
167.
Pande P, Shrestha S, Park J, Serafino MJ, Gimenez-Conti I, Brandon J, et al. Automated classification of optical coherence tomography images for the diagnosis of oral malignancy in the hamster cheek pouch. J Biomed Opt. 2014;19(8):086022.PubMedPubMedCentral
168.
Wang D, Fu L, Wang X, Gong Z, Samuelson S, Duan C, et al. Endoscopic swept-source optical coherence tomography based on a two-axis microelectromechanical system mirror. J Biomed Opt. 2013;18(8):86005.PubMed
169.
Wessels R, De Bruin DM, Faber DJ, Van Leeuwen TG, Van Beurden M, Ruers TJ. Optical biopsy of epithelial cancers by optical coherence tomography (OCT). Lasers Med Sci. 2014;29(3):1297–305.PubMed
170.
Wax A, Pyhtila JW, Graf RN, Nines R, Boone CW, Dasari RR, et al. Prospective grading of neoplastic change in rat esophagus epithelium using angle-resolved low-coherence interferometry. J Biomed Opt. 2005;10(5):051604.PubMed
171.
Chalut KJ, Kresty LA, Pyhtila JW, Nines R, Baird M, Steele VE, et al. In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry. Cancer Epidemiol Biomarkers Prev. 2007;16(2):223–7.PubMed
172.
Terry N, Zhu Y, Thacker JK, Migaly J, Guy C, Mantyh CR, et al. Detection of intestinal dysplasia using angle-resolved low coherence interferometry. J Biomed Opt. 2011;16(10):106002.PubMedPubMedCentral
173.
Zhu Y, Terry NG, Wax A. Angle-resolved low-coherence interferometry: an optical biopsy technique for clinical detection of dysplasia in Barrett’s esophagus. Expert Rev Gastroenterol Hepatol. 2012;6(1):37–41.PubMedPubMedCentral
174.
Wax A, Chalut KJ. Nuclear morphology measurements with angle-resolved 162- low coherence interferometry for application to cell biology and early cancer detection. Stud Health Technol Inform. 2013;185:129–51.PubMed
175.
Terry NG, Zhu Y, Rinehart MT, Brown WJ, Gebhart SC, Bright S, et al. Detection of dysplasia in Barrett’s esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology. 2011;140(1):42–50.PubMed
176.
Wax A, Terry NG, Dellon ES, Shaheen NJ. Angle-resolved low coherence interferometry for detection of dysplasia in Barrett’s esophagus. Gastroenterology. 2011;141(2):443–7. 447.e1-2.PubMedPubMedCentral
177.
Adalsteinsson E, Spielman DM, Pauly JM, Terris DJ, Sommer G, Macovski A. Feasibility study of lactate imaging of head and neck tumors. NMR Biomed. 1998;11:360–9.PubMed
178.
El-Sayed S, Bezabeh T, Odlum O, Patel R, Ahing S, MacDonald K, et al. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck. 2002;24(8):766–72.PubMed
179.
Maheshwari SR, Mukherji SK, Neelon B, Schiro S, Fatterpekar GM, Stone JA, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. Am J Neuroradiol. 2000;21:1930–5.PubMed
180.
Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, Blackstock W. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. Am J Neuroradiol. 1997;18:1057–72.PubMed
181.
Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer. 2003;97(4):1015–24.PubMed
182.
Bhawal UK, Ozaki Y, Nishimura M, Sugiyama M, Sasahira T, Nomura Y, et al. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Oncology. 2005;69(3):246–55.PubMed
183.
Ujpál M, Barabás J, Kovalszky I, Szabó G, Németh Z, Gábris K, et al. A preliminary comparative study of the prognostic implications of type 2 diabetes mellitus for patients with primary gingival carcinoma treated with surgery and radiation therapy. J Oral Maxillofac Surg. 2007;65(3):452–6.PubMed
184.
Pogue BW, Krishnaswamy V, Laughney A, Paulsen KD, Hoopes PJ, García Allende PB. Spectral scatter scanning system for surgical margin detection. Head & Neck Oncology. 2009;1 Suppl 1:012.
185.
Conti C, Ferraris P, Giorgini E, Rubini C, Sabbatini S, Tosi G. Microimaging FT-IR of Head and Neck Tumours. The case of salivary glands. Head & Neck Oncology. 2009;1 Suppl 1:013.
186.
Epstein JB, Sciubba JJ, Banasek TE, Hay LJ. Failure to diagnose and delayed diagnosis of cancer: medicolegal issues. J Am Dent Assoc. 2009;140(12):1494–503.PubMed
187.
188.
189.
Wei F, Wong DT. Point-of-care platforms for salivary diagnostics. Chinese J Dent Res. 2012;15:7–15.
190.
Priyanka N. Recent approaches in saliva as a credible periodontal diagnostic and prognostic marker. AOSR. 2012;2(1):40–6.
191.
Metadata
Title
Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma - a systematic review
Author
Esam Omar
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Head & Face Medicine / Issue 1/2015
Electronic ISSN: 1746-160X
DOI
https://doi.org/10.1186/s13005-015-0063-z

Other articles of this Issue 1/2015

Head & Face Medicine 1/2015 Go to the issue

Editorial

Editor's note: new biomaterials for dental and craniomaxillofacial applications section

Research

Enamel surface alterations after repeated conditioning with HCl

Research

Does facial soft tissue protect against zygomatic fractures? Results of a finite element analysis

Reviewer acknowledgement

Reviewer acknowledgement 2014

Research

Effects of a novel magnetic orthopedic appliance (MOA-III) on the dentofacial complex in mild to moderate skeletal class III children

Review

Coronectomy as a surgical approach to impacted mandibular third molars: a systematic review